retatrutide needles Delivers Bariatric-Level Weight Loss in Pivotal Phase 3 TRIUMPH-1 Trial Retatrutide for weight loss: how

A 2024 study found that patients taking semaglutide medications were significantly more likely to develop NAION compared to certain other diabetes medications, raising concern about a possible association between GLP-1 drugs and optic nerve injury

Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study

4) While its probably not a miracle drug, its not unreasonable to look out in a decade or so and see that we have solved the problem of obesity

Liver health (MASLD/MASH): in people with metabolic dysfunction,associated fatty liver disease, GLP-1s (especially semaglutide) improve steatosis and some histologic endpoints

, Monuki, E

The crazy thing here isn't just that the revenue and the focus is so concentrated